{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T17:43:18Z","timestamp":1789839798353,"version":"4.0.1"},"reference-count":209,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.4158\/ep.16.s3.1","type":"journal-article","created":{"date-parts":[[2013,4,5]],"date-time":"2013-04-05T22:39:47Z","timestamp":1365201587000},"page":"1-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":290,"special_numbering":"S3","title":["American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Postmenopausal Osteoporosis"],"prefix":"10.1016","volume":"16","author":[{"given":"Nelson B.","family":"Watts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Bilezikian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline M.","family":"Camacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan L.","family":"Greenspan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven T.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen F.","family":"Hodgson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kleerekoper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjorie M.","family":"Luckey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"McClung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel Pessah","family":"Pollack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Petak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson B.","family":"Watts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Bilezikian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline M.","family":"Camacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan L.","family":"Greenspan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven T.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen F.","family":"Hodgson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kleerekoper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjorie M.","family":"Luckey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"McClung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel Pessah","family":"Pollack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Petak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald A.","family":"Bergman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Binkley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul D.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4158\/EP.16.S3.1_bb0005","doi-asserted-by":"crossref","first-page":"270","DOI":"10.4158\/EP.16.2.270","article-title":"American Association of Clinical Endocrinologists protocol for standardized production of clinical practice guidelines\u20142010 update","volume":"16","author":"Mechanick","year":"2010","journal-title":"Endocr Pract."},{"key":"10.4158\/EP.16.S3.1_bb0010","first-page":"353","article-title":"American Association of Clinical Endocrinologists protocol for standardized production of clinical practice guidelines [published correction appears in Endocr Pract. 2008;14:802-803]","volume":"10","author":"Mechanick","year":"2004","journal-title":"Endocr Pract."},{"key":"10.4158\/EP.16.S3.1_bb0015","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1001\/jama.285.6.785","article-title":"Osteoporosis prevention, diagnosis, and therapy","volume":"285","author":"NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy","year":"2001","journal-title":"JAMA."},{"key":"10.4158\/EP.16.S3.1_bb0020","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/jbmr.5650090802","article-title":"The diagnosis of osteoporosis","volume":"9","author":"Kanis","year":"1994","journal-title":"J Bone Miner Res."},{"key":"10.4158\/EP.16.S3.1_bb0025","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1056\/NEJMra053077","article-title":"Bone quality\u2014the material and structural basis of bone strength and fragility","volume":"354","author":"Seeman","year":"2006","journal-title":"N Engl J Med."},{"key":"10.4158\/EP.16.S3.1_bb0030","series-title":"America\u2019s Bone Health: The State of Osteoporosis and Low Bone Mass in Our Nation","author":"National Osteoporosis Foundation","year":"2002"},{"key":"10.4158\/EP.16.S3.1_bb0035","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0140-6736(02)08657-9","article-title":"Epidemiology and outcomes of osteoporotic fractures","volume":"359","author":"Cummings","year":"2002","journal-title":"Lancet."},{"key":"10.4158\/EP.16.S3.1_bb0040","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1359\/jbmr.1997.12.11.1761","article-title":"Prevalence of low femoral bone density in older U.S. adults from NHANES III","volume":"12","author":"Looker","year":"1997","journal-title":"J Bone Miner Res."},{"key":"10.4158\/EP.16.S3.1_bb0045","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1385\/JCD:2:3:343","article-title":"Discordance in patient classification using T-scores","volume":"2","author":"Faulkner","year":"1999","journal-title":"J Clin Densitom."},{"key":"10.4158\/EP.16.S3.1_bb0050","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/BF01623271","article-title":"Prevalence and incidence of vertebral deformities","volume":"3","author":"Melton","year":"1993","journal-title":"Osteoporos Int."},{"key":"10.4158\/EP.16.S3.1_bb0055","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1359\/jbmr.061113","article-title":"Incidence and economic burden of osteoporosis-related fractures in the United States, 20052025","volume":"22","author":"Burge","year":"2007","journal-title":"J Bone Miner Res."},{"key":"10.4158\/EP.16.S3.1_bb0060","first-page":"e69","article-title":"Heart disease and stroke statistics\u20142007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee [published corrections appear in Circulation. 2007;115:e172 and 2010;122:e9]","volume":"115","author":"Rosamond","year":"2007","journal-title":"Circulation"},{"key":"10.4158\/EP.16.S3.1_bb0065","series-title":"Cancer Facts and Figures 2006","author":"American Cancer Society","year":"2006"},{"key":"10.4158\/EP.16.S3.1_bb0070","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s001980050197","article-title":"Survival after hip fracture: short-and long-term excess mortality according to age and gender","volume":"10","author":"Fors\u00e9n","year":"1999","journal-title":"Osteoporos Int."},{"key":"10.4158\/EP.16.S3.1_bb0075","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/BF01626602","article-title":"Age-related hip fractures in men: clinical spectrum and short-term outcomes","volume":"5","author":"Po\u00f3r","year":"1995","journal-title":"Osteoporos Int."},{"key":"10.4158\/EP.16.S3.1_bb0080","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00198-002-1313-z","article-title":"Hospital care of osteoporosis-related vertebral fractures","volume":"14","author":"Gehlbach","year":"2003","journal-title":"Osteoporos Int."},{"key":"10.4158\/EP.16.S3.1_bb0085","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1359\/jbmr.1997.12.1.24","article-title":"Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation","volume":"12","author":"Ray","year":"1997","journal-title":"J Bone Miner Res."},{"key":"10.4158\/EP.16.S3.1_bb0090","series-title":"Osteoporosis","first-page":"819","article-title":"Outcomes of osteoporotic fracture","author":"Greendale","year":"2001"},{"key":"10.4158\/EP.16.S3.1_bb0095","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00198-008-0742-8","article-title":"Secular trends in hip fracture incidence and recurrence","volume":"20","author":"Melton","year":"2009","journal-title":"Osteoporos Int."},{"key":"10.4158\/EP.16.S3.1_bb0100","first-page":"1221","article-title":"Fatalities and injuries from falls among older adults\u2014United States, 1993-2003 and 2001-2005 [published correction appears in MMWR Morb Mortal Weekly Rep. 2006;55:1303]","volume":"55","author":"Centers for Disease Control and Prevention (CDC)","year":"2006","journal-title":"MMWR Morb Mortal Weekly Rep."},{"key":"10.4158\/EP.16.S3.1_bb0105","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1001\/jama.2009.1231","article-title":"Trends in hip fracture rates in Canada","volume":"302","author":"Leslie","year":"2009","journal-title":"JAMA."},{"key":"10.4158\/EP.16.S3.1_bb0110","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S8756-3282(98)00182-3","article-title":"The changing picture of hip fractures: dramatic change in age distribution and no change in age-adjusted incidence within 10 years in Central Finland","volume":"24","author":"Huusko","year":"1999","journal-title":"Bone."},{"key":"10.4158\/EP.16.S3.1_bb0115","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s00198-002-1336-5","article-title":"Osteoporosis disease management in a rural health care population: hip fracture reduction and reduced costs in postmenopausal women after 5 years","volume":"14","author":"Newman","year":"2003","journal-title":"Osteoporos Int."},{"issue":"suppl 4","key":"10.4158\/EP.16.S3.1_bb0120","doi-asserted-by":"crossref","first-page":"188","DOI":"10.2106\/JBJS.H.00628","article-title":"Osteoporosis disease management: the role of the orthopaedic surgeon","volume":"90","author":"Dell","year":"2008","journal-title":"J Bone Joint Surg Am."},{"key":"10.4158\/EP.16.S3.1_bb0125","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.bone.2006.12.063","article-title":"Incidence of hip fracture over a 10-year period (1991-2000): reversal of a secular trend","volume":"40","author":"Chevalley","year":"2007","journal-title":"Bone."},{"key":"10.4158\/EP.16.S3.1_bb0130","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1359\/jbmr.090523","article-title":"Health care expenditures associated with skeletal fractures among Medicare beneficiaries, 1999-2005","volume":"24","author":"Kilgore","year":"2009","journal-title":"J Bone Miner Res."},{"key":"10.4158\/EP.16.S3.1_bb0135","first-page":"319","article-title":"Trends in drug prescribing for osteoporosis after hip fracture, 19952004","volume":"35","author":"Cadarette","year":"2008","journal-title":"J Rheumatol."},{"key":"10.4158\/EP.16.S3.1_bb0140","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S8756-3282(03)00062-0","article-title":"Peak spine and femoral neck bone mass in young women","volume":"32","author":"Lin","year":"2003","journal-title":"Bone."},{"key":"10.4158\/EP.16.S3.1_bb0145","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1172\/JCI117034","article-title":"Timing of peak bone mass in Caucasian females and its implication for the prevention of osteoporosis: inference from a cross-sectional model","volume":"93","author":"Matkovic","year":"1994","journal-title":"J Clin Invest."},{"key":"10.4158\/EP.16.S3.1_bb0150","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1007\/s00198-005-1948-7","article-title":"Genetic and environmental influences on bone mineral density in pre-and post-menopausal women","volume":"16","author":"Brown","year":"2005","journal-title":"Osteoporos Int."},{"key":"10.4158\/EP.16.S3.1_bb0155","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1385\/ENDO:17:1:55","article-title":"Role of genetics in osteoporosis","volume":"17","author":"Recker","year":"2002","journal-title":"Endocrine."},{"key":"10.4158\/EP.16.S3.1_bb0160","first-page":"27","article-title":"Genetic regulation of bone mass and susceptibility to osteoporosis","volume":"6","author":"Williams","year":"2006","journal-title":"J Musculoskel Neuron Interact."},{"key":"10.4158\/EP.16.S3.1_bb0165","doi-asserted-by":"crossref","first-page":"528","DOI":"10.7326\/0003-4819-151-8-200910200-00006","article-title":"Collaborative meta-analysis: associations of 150 candidate genes with osteoporosis and osteoporotic fracture","volume":"151","author":"Richards","year":"2009","journal-title":"Ann Intern Med."},{"key":"10.4158\/EP.16.S3.1_bb0170","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.1210\/jc.2007-0646","article-title":"The role of receptor activator of nuclear factor-kappaB (RANK)\/RANK ligand\/osteoprotegerin: clinical implications","volume":"92","author":"Vega","year":"2007","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.16.S3.1_bb0175","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1001\/jama.298.20.2381","article-title":"High-trauma fractures and low bone mineral density in older women and men","volume":"298","author":"Mackey","year":"2007","journal-title":"JAMA."},{"key":"10.4158\/EP.16.S3.1_bb0180","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ocl.2006.08.003","article-title":"Hip fracture and its consequences: differences between men and women","volume":"37","author":"Orwig","year":"2006","journal-title":"Orthop Clin North Am."},{"key":"10.4158\/EP.16.S3.1_bb0185","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1001\/jama.292.23.2890","article-title":"Does this woman have osteoporosis?","volume":"292","author":"Green","year":"2004","journal-title":"JAMA."},{"key":"10.4158\/EP.16.S3.1_bb0190","series-title":"Assessment of Osteoporosis at the Primary Health Care Level: WHO Scientific Technical Report","author":"Kanis","year":"2008"},{"key":"10.4158\/EP.16.S3.1_bb0195","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1359\/jbmr.090402","article-title":"FRAX facts","volume":"24","author":"Watts","year":"2009","journal-title":"J Bone Miner Res."},{"key":"10.4158\/EP.16.S3.1_bb0200","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jocd.2008.04.003","article-title":"National Osteoporosis Foundation 2008 Clinician\u2019s Guide to Prevention and Treatment of Osteoporosis and the World Health Organization Fracture Risk Assessment Tool (FRAX): what they mean to the bone densitometrist and bone technologist","volume":"11","author":"Watts","year":"2008","journal-title":"J Clin Densitom."},{"key":"10.4158\/EP.16.S3.1_bb0205","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s00198-006-0319-3","article-title":"Performance of the Osteoporosis Self-Assessment Tool in ruling out low bone mineral density in postmenopausal women: a systematic review [published correction appears in Osteoporos Int. 2007;18:1307]","volume":"18","author":"Rud","year":"2007","journal-title":"Osteoporos Int."},{"key":"10.4158\/EP.16.S3.1_bb0210","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s00198-007-0343-y","article-title":"The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women","volume":"18","author":"Kanis","year":"2007","journal-title":"Osteoporos Int."},{"key":"10.4158\/EP.16.S3.1_bb0215","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.bone.2004.03.024","article-title":"A meta-analysis of previous fracture and subsequent fracture risk","volume":"35","author":"Kanis","year":"2004","journal-title":"Bone."},{"key":"10.4158\/EP.16.S3.1_bb0220","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1359\/jbmr.2000.15.4.721","article-title":"Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis","volume":"15","author":"Klotzbuecher","year":"2000","journal-title":"J Bone Miner Res."},{"key":"10.4158\/EP.16.S3.1_bb0225","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1359\/jbmr.060708","article-title":"BMD and risk of hip and nonvertebral fractures in older men: a prospective study and comparison with older women","volume":"21","author":"Cummings","year":"2006","journal-title":"J Bone Miner Res."},{"key":"10.4158\/EP.16.S3.1_bb0230","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1359\/JBMR.050304","article-title":"Predictive value of BMD for hip and other fractures [published correction appears in J Bone Miner Res. 2007;22:774]","volume":"20","author":"Johnell","year":"2005","journal-title":"J Bone Miner Res."},{"key":"10.4158\/EP.16.S3.1_bb0235","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1136\/bmj.312.7041.1254","article-title":"Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures","volume":"312","author":"Marshall","year":"1996","journal-title":"BMJ."},{"key":"10.4158\/EP.16.S3.1_bb0240","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s001980170006","article-title":"Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds","volume":"12","author":"Kanis","year":"2001","journal-title":"Osteoporos Int."},{"key":"10.4158\/EP.16.S3.1_bb0245","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00198-006-0290-z","article-title":"Influence of fall related factors and bone strength on fracture risk in the frail elderly","volume":"18","author":"Sambrook","year":"2007","journal-title":"Osteoporos Int."},{"key":"10.4158\/EP.16.S3.1_bb0250","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11154-006-9005-1","article-title":"Anorexia nervosa and osteoporosis","volume":"7","author":"Misra","year":"2006","journal-title":"Rev Endocr Metab Disord."},{"key":"10.4158\/EP.16.S3.1_bb0255","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S1297-319X(01)00295-0","article-title":"Protein intake and bone disorders in the elderly","volume":"68","author":"Rizzoli","year":"2001","journal-title":"Joint Bone Spine."},{"key":"10.4158\/EP.16.S3.1_bb0260","doi-asserted-by":"crossref","first-page":"801","DOI":"10.7326\/0003-4819-128-10-199805150-00002","article-title":"Protein supplements increase serum insulin-like growth factor-I levels and attenuate proximal femur bone loss in patients with recent hip fracture: a randomized, double-blind, placebo-controlled trial","volume":"128","author":"Sch\u00fcrch","year":"1998","journal-title":"Ann Intern Med."},{"key":"10.4158\/EP.16.S3.1_bb0265","doi-asserted-by":"crossref","unstructured":"Ross AC, Manson JE, Abrams SA, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know [published online ahead of print November 29, 2010]. J Clin Endocrinol Metab. doi:https:\/\/doi.org\/10.1210\/jc.2010-2704.","DOI":"10.1210\/jc.2010-2704"},{"key":"10.4158\/EP.16.S3.1_bb0270","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0022-3476(95)70348-9","article-title":"Effects of dairy products on bone and body composition in pubertal girls","volume":"126","author":"Chan","year":"1995","journal-title":"J Pediatr."},{"key":"10.4158\/EP.16.S3.1_bb0275","first-page":"341","article-title":"The effects of a high calcium dairy food on bone health in prepubertal children in New Zealand","volume":"13","author":"Gibbons","year":"2004","journal-title":"Asia Pac J Clin Nutr."},{"key":"10.4158\/EP.16.S3.1_bb0280","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1007\/s00198-005-1963-8","article-title":"A prospective study of the effects of 1-year calcium-fortified soy milk supplementation on dietary calcium intake and bone health in Chinese adolescent girls aged 14 to 16","volume":"16","author":"Ho","year":"2005","journal-title":"Osteoporos Int."},{"key":"10.4158\/EP.16.S3.1_bb0285","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s003940070004","article-title":"Effects of dairy food supplements on bone mineral density in teenage girls","volume":"39","author":"Merrilees","year":"2000","journal-title":"Eur J Nutr."},{"key":"10.4158\/EP.16.S3.1_bb0290","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1136\/bmj.38950.561400.55","article-title":"Effects of calcium supplementation on bone density in healthy children: meta-analysis of randomised controlled trials","volume":"333","author":"Winzenberg","year":"2006","journal-title":"BMJ."},{"key":"10.4158\/EP.16.S3.1_bb0295","series-title":"Dietary intake of vitamins, minerals, and fiber of persons ages 2 months and over in the United States: Third National Health and Nutrition Examination Survey, phase 1, 1988-91. Advance data from vital and health statistics, No. 258","first-page":"1","author":"Alaimo","year":"1994"},{"key":"10.4158\/EP.16.S3.1_bb0300","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1136\/bmj.330.7498.1003","article-title":"Randomised controlled trial of calcium and supplementation with cholecalciferol (vitamin D3) for prevention of fractures in primary care","volume":"330","author":"Porthouse","year":"2005","journal-title":"BMJ."},{"key":"10.4158\/EP.16.S3.1_bb0305","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1210\/er.2001-7002","article-title":"Meta-analyses of therapies for postmenopausal osteoporosis, VII: meta-analysis of calcium supplementation for the prevention of postmenopausal osteoporosis","volume":"23","author":"Shea","year":"2002","journal-title":"Endocr Rev."},{"key":"10.4158\/EP.16.S3.1_bb0310","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJMoa055218","article-title":"(Women\u2019s Health Initiative Investigators). Calcium plus vitamin D supplementation and the risk of fractures","volume":"354","author":"Jackson","year":"2006","journal-title":"N Engl J Med."},{"key":"10.4158\/EP.16.S3.1_bb0315","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/S0140-6736(05)63013-9","article-title":"Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium OR vitamin D, RECORD): a randomised placebo-controlled trial","volume":"365","author":"Grant","year":"2005","journal-title":"Lancet"},{"key":"10.4158\/EP.16.S3.1_bb0320","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1210\/jc.2004-2364","article-title":"Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy","volume":"90","author":"Holick","year":"2005","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.16.S3.1_bb0325","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s00198-005-1867-7","article-title":"Estimates of optimal vitamin D status","volume":"16","author":"Dawson-Hughes","year":"2005","journal-title":"Osteoporos Int."},{"key":"10.4158\/EP.16.S3.1_bb0330","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1210\/jc.2006-2250","article-title":"Low vitamin D status despite abundant sun exposure","volume":"92","author":"Binkley","year":"2007","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.16.S3.1_bb0335","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1001\/jama.293.18.2257","article-title":"Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials","volume":"293","author":"Bischoff-Ferrari","year":"2005","journal-title":"JAMA."},{"key":"10.4158\/EP.16.S3.1_bb0340","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1001\/jama.291.16.1999","article-title":"Effect of vitamin D on falls: a meta-analysis","volume":"291","author":"Bischoff-Ferrari","year":"2004","journal-title":"JAMA."},{"key":"10.4158\/EP.16.S3.1_bb0345","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/s00198-005-0030-9","article-title":"Is fall prevention by vitamin D mediated by a change in postural or dynamic balance?","volume":"17","author":"Bischoff-Ferrari","year":"2006","journal-title":"Osteoporos Int."},{"key":"10.4158\/EP.16.S3.1_bb0350","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1359\/jbmr.2000.15.6.1113","article-title":"Effects of a short-term vitamin D and calcium supplementation on body sway and secondary hyperparathyroidism in elderly women","volume":"15","author":"Pfeifer","year":"2000","journal-title":"J Bone Miner Res."},{"key":"10.4158\/EP.16.S3.1_bb0355","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1001\/archinte.167.16.1730","article-title":"Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials","volume":"167","author":"Autier","year":"2007","journal-title":"Arch Intern Med."},{"key":"10.4158\/EP.16.S3.1_bb0360","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1210\/jc.2007-2308","article-title":"Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D","volume":"93","author":"Holick","year":"2008","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.16.S3.1_bb0365","doi-asserted-by":"crossref","first-page":"5387","DOI":"10.1210\/jc.2004-0360","article-title":"Vitamin D2 is much less effective than vitamin D3 in humans","volume":"89","author":"Armas","year":"2004","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.16.S3.1_bb0370","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/07315724.1994.10718439","article-title":"Effect of magnesium on the intestinal absorption of calcium in man","volume":"13","author":"Spencer","year":"1994","journal-title":"J Am Coll Nutr."},{"key":"10.4158\/EP.16.S3.1_bb0375","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1345\/aph.1G028","article-title":"Effect of vitamin A on fracture risk","volume":"39","author":"Jackson","year":"2005","journal-title":"Ann Pharmacother."},{"key":"10.4158\/EP.16.S3.1_bb0380","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00223-002-2084-4","article-title":"Vitamin K1 supplementation retards bone loss in postmenopausal women between 50 and 60 years of age","volume":"73","author":"Braam","year":"2003","journal-title":"Calcif Tissue Int."},{"key":"10.4158\/EP.16.S3.1_bb0385","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1001\/jama.285.11.1482","article-title":"Ipriflavone in the treatment of postmenopausal osteoporosis: a randomized controlled trial","volume":"285","author":"Alexandersen","year":"2001","journal-title":"JAMA."},{"key":"10.4158\/EP.16.S3.1_bb0390","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/ajcn\/79.2.326","article-title":"The effects of phytoestrogen isoflavones on bone density in women: a double-blind, randomized, placebo-controlled trial","volume":"79","author":"Atkinson","year":"2004","journal-title":"Am J Clin Nutr."},{"key":"10.4158\/EP.16.S3.1_bb0395","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/01.GME.0000097845.95550.71","article-title":"The effect of soy protein isolate on bone metabolism","volume":"11","author":"Gallagher","year":"2004","journal-title":"Menopause."},{"key":"10.4158\/EP.16.S3.1_bb0400","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00198-004-1734-y","article-title":"Alcohol intake as a risk factor for fracture","volume":"16","author":"Kanis","year":"2005","journal-title":"Osteoporos Int."},{"key":"10.4158\/EP.16.S3.1_bb0405","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s00198-006-0109-y","article-title":"Coffee, tea and caffeine consumption in relation to osteoporotic fracture risk in a cohort of Swedish women","volume":"17","author":"Hallstr\u00f6m","year":"2006","journal-title":"Osteoporos Int."},{"key":"10.4158\/EP.16.S3.1_bb0410","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1093\/oxfordjournals.aje.a115709","article-title":"Caffeine and the risk of hip fracture: the Framingham Study","volume":"132","author":"Kiel","year":"1990","journal-title":"Am J Epidemiol."},{"key":"10.4158\/EP.16.S3.1_bb0415","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00198-004-1640-3","article-title":"Smoking and fracture risk: a meta-analysis","volume":"16","author":"Kanis","year":"2005","journal-title":"Osteoporos Int."},{"key":"10.4158\/EP.16.S3.1_bb0420","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/jbmr.5650050608","article-title":"Muscle strength as a predictor of bone mineral density in young women","volume":"5","author":"Snow-Harter","year":"1990","journal-title":"J Bone Miner Res."},{"key":"10.4158\/EP.16.S3.1_bb0425","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/jbmr.5650070706","article-title":"Effects of resistance and endurance exercise on bone mineral status of young women: a randomized exercise intervention trial","volume":"7","author":"Snow-Harter","year":"1992","journal-title":"J Bone Miner Res."},{"key":"10.4158\/EP.16.S3.1_bb0430","doi-asserted-by":"crossref","first-page":"M599","DOI":"10.1093\/gerona\/57.9.M599","article-title":"Exercise and lumbar spine bone mineral density in postmenopausal women: a meta-analysis of individual patient data","volume":"57","author":"Kelley","year":"2002","journal-title":"J Gerontol A Biol Sci Med Sci."},{"key":"10.4158\/EP.16.S3.1_bb0435","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1006\/pmed.2002.1017","article-title":"Application of a falls prevention program for older people to primary health care practice","volume":"34","author":"Gardner","year":"2002","journal-title":"Prev Med."},{"key":"10.4158\/EP.16.S3.1_bb0440","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1046\/j.1532-5415.2002.50218.x","article-title":"Preventing injuries in older people by preventing falls: a meta-analysis of individual-level data","volume":"50","author":"Robertson","year":"2002","journal-title":"J Am Geriatr Soc."},{"key":"10.4158\/EP.16.S3.1_bb0445","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1136\/bmj.38753.375324.7C","article-title":"Effectiveness of hip protectors for preventing hip fractures in elderly people: systematic review","volume":"332","author":"Parker","year":"2006","journal-title":"BMJ."},{"key":"10.4158\/EP.16.S3.1_bb0450","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1007\/s00198-005-1932-2","article-title":"Do hip protectors decrease the risk of hip fracture in institutional and community-dwelling elderly? A systematic review and meta-analysis of randomized controlled trials","volume":"16","author":"Sawka","year":"2005","journal-title":"Osteoporos Int."},{"key":"10.4158\/EP.16.S3.1_bb0455","first-page":"1607","article-title":"Cost-effectiveness of hip protectors in the prevention of osteoporosis related hip fractures in elderly nursing home residents","volume":"31","author":"Singh","year":"2004","journal-title":"J Rheumatol."},{"key":"10.4158\/EP.16.S3.1_bb0460","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00198-003-1382-7","article-title":"The Amsterdam Hip Protector Study: compliance and determinants of compliance","volume":"14","author":"van Schoor","year":"2003","journal-title":"OsteoporosInt."},{"key":"10.4158\/EP.16.S3.1_bb0465","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1532-5415.2004.52103.x","article-title":"Predictors of adherence to the use of hip protectors in nursing home residents","volume":"52","author":"Warnke","year":"2004","journal-title":"J Am Geriatr Soc."},{"key":"10.4158\/EP.16.S3.1_bb0470","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1001\/jama.298.4.413","article-title":"Efficacy of a hip protector to prevent hip fracture in nursing home residents: the HIP PRO randomized controlled trial","volume":"298","author":"Kiel","year":"2007","journal-title":"JAMA."},{"key":"10.4158\/EP.16.S3.1_bb0475","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1177\/0269215509339002","article-title":"Effects of exercise programmes on quality of life in osteoporotic and osteopenic postmenopausal women: a systematic review and meta-analysis","volume":"23","author":"Li","year":"2009","journal-title":"Clin Rehabil."},{"key":"10.4158\/EP.16.S3.1_bb0480","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1210\/jc.2006-1178","article-title":"Clinical review: clinical applications of vertebral fracture assessment by dualenergy x-ray absorptiometry","volume":"91","author":"Lewiecki","year":"2006","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.16.S3.1_bb0485","first-page":"747","article-title":"Kyphosis does not equal vertebral fractures: the Rancho Bernardo study","volume":"31","author":"Schneider","year":"2004","journal-title":"J Rheumatol."},{"key":"10.4158\/EP.16.S3.1_bb0490","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00198-004-1709-z","article-title":"Accuracy of height loss during prospective monitoring for detection of incident vertebral fractures","volume":"16","author":"Siminoski","year":"2005","journal-title":"Osteoporos Int."},{"key":"10.4158\/EP.16.S3.1_bb0495","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s00198-005-2017-y","article-title":"The accuracy of historical height loss for the detection of vertebral fractures in postmenopausal women","volume":"17","author":"Siminoski","year":"2006","journal-title":"Osteoporos Int."},{"key":"10.4158\/EP.16.S3.1_bb0500","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00198-009-1007-x","article-title":"Population screening for osteoporosis risk: a randomised control trial of medication use and fracture risk","volume":"21","author":"Barr","year":"2009","journal-title":"Osteoporos Int."},{"key":"10.4158\/EP.16.S3.1_bb0505","doi-asserted-by":"crossref","first-page":"4431","DOI":"10.1210\/jc.2002-020275","article-title":"Yield of laboratory testing to identify secondary contributors to osteoporosis in otherwise healthy women","volume":"87","author":"Tannenbaum","year":"2002","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.16.S3.1_bb0510","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1210\/jc.2002-021660","article-title":"Recommended testing in patients with low bone density [with author reply]","volume":"88","author":"Barzel","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.16.S3.1_bb0515","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0002-9343(96)00387-7","article-title":"Hormone replacement therapy in postmenopausal women: urinary N-telopeptide of type I collagen monitors therapeutic effect and predicts response of bone mineral density","volume":"102","author":"Chesnut","year":"1997","journal-title":"Am J Med."},{"key":"10.4158\/EP.16.S3.1_bb0520","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/jbmr.5650111021","article-title":"Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study","volume":"11","author":"Garnero","year":"1996","journal-title":"J Bone Miner Res."},{"key":"10.4158\/EP.16.S3.1_bb0525","first-page":"3537","article-title":"Early changes in serum N-telopeptide and C-telopeptide cross-linked collagen type 1 predict long-term response to alendronate therapy in elderly women","volume":"85","author":"Greenspan","year":"2000","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.16.S3.1_bb0530","series-title":"Clinician\u2019s Guide to Prevention and Treatment of Osteoporosis","author":"National Osteoporosis Foundation","year":"2008"},{"key":"10.4158\/EP.16.S3.1_bb0535","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1359\/jbmr.070112","article-title":"Alendronate treatment in women with normal to severely impaired renal function: an analysis of the Fracture Intervention Trial","volume":"22","author":"Jamal","year":"2007","journal-title":"J Bone Miner Res."},{"key":"10.4158\/EP.16.S3.1_bb0540","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1359\/JBMR.050817","article-title":"Safety and efficacy of risedronate in patients with age-related reduced renal function as estimated by the Cockcroft and Gault method: a pooled analysis of nine clinical trials","volume":"20","author":"Miller","year":"2005","journal-title":"J Bone Miner Res."},{"issue":"suppl 113","key":"10.4158\/EP.16.S3.1_bb0545","first-page":"S1","article-title":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorders (CKD-MBD)","volume":"76","author":"Disease","year":"2009","journal-title":"Kidney Int Suppl."},{"key":"10.4158\/EP.16.S3.1_bb0550","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/BF02556671","article-title":"The acute-phase response after bisphosphonate administration","volume":"41","author":"Adami","year":"1987","journal-title":"Calcif Tissue Int."},{"key":"10.4158\/EP.16.S3.1_bb0555","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1046\/j.1365-2141.2002.03835_4.x","article-title":"Severe increase in creatinine with hypocalcaemia in thalidomide-treated myeloma patients receiving zoledronic acid infusions","volume":"119","author":"Jones","year":"2002","journal-title":"Br J Haematol."},{"key":"10.4158\/EP.16.S3.1_bb0560","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJM200310233491721","article-title":"Renal failure with the use of zoledronic acid [letter]","volume":"349","author":"Chang","year":"2003","journal-title":"N Engl J Med."},{"key":"10.4158\/EP.16.S3.1_bb0565","first-page":"1678","article-title":"Renal failure with the use of zoledronic acid [reply to letter]","volume":"349","author":"Tarassoff","year":"2003","journal-title":"N Engl J Med."},{"key":"10.4158\/EP.16.S3.1_bb0570","first-page":"13","article-title":"Zoledronic acid for osteoporosis (marketed as Reclast): renal impairment and acute renal failure","volume":"2","author":"FDA U. S. Food and Drug Administration","year":"2009","journal-title":"Drug Safety Newsletter"},{"key":"10.4158\/EP.16.S3.1_bb0575","first-page":"346","article-title":"Alendronate and risedronate: reports of severe bone, joint, and muscle pain","volume":"165","author":"Wysowski","year":"2005","journal-title":"Arch Intern Med."},{"key":"10.4158\/EP.16.S3.1_bb0580","doi-asserted-by":"crossref","first-page":"753","DOI":"10.7326\/0003-4819-144-10-200605160-00009","article-title":"Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws [published correction appears in Ann Intern Med. 2006;145:235]","volume":"144","author":"Woo","year":"2006","journal-title":"Ann Intern Med."},{"key":"10.4158\/EP.16.S3.1_bb0585","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1056\/NEJMp068157","article-title":"Osteonecrosis of the jaw\u2014do bisphosphonates pose a risk?","volume":"355","author":"Bilezikian","year":"2006","journal-title":"N Engl J Med."},{"key":"10.4158\/EP.16.S3.1_bb0590","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1359\/jbmr.0707onj","article-title":"Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research","volume":"22","author":"Khosla","year":"2007","journal-title":"J Bone Miner Res."},{"key":"10.4158\/EP.16.S3.1_bb0595","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1001\/archinte.160.4.517","article-title":"Upper gastrointestinal tract safety profile of alendronate: the Fracture Intervention Trial","volume":"160","author":"Bauer","year":"2000","journal-title":"Arch Intern Med."},{"key":"10.4158\/EP.16.S3.1_bb0600","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1007\/s00198-008-0805-x","article-title":"Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study","volume":"20","author":"Lenart","year":"2009","journal-title":"Osteoporos Int."},{"key":"10.4158\/EP.16.S3.1_bb0605","first-page":"51","article-title":"The clinical tolerability profile of alendronate","volume":"101","author":"Watts","year":"1999","journal-title":"Int J Clin Pract Suppl."},{"key":"10.4158\/EP.16.S3.1_bb0610","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1056\/NEJM199610033351403","article-title":"Esophagitis associated with the use of alendronate","volume":"335","author":"de Groen","year":"1996","journal-title":"N Engl J Med."},{"key":"10.4158\/EP.16.S3.1_bb0615","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1002\/jbmr.253","article-title":"Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research","volume":"25","author":"Shane","year":"2010","journal-title":"J Bone Miner Res."},{"key":"10.4158\/EP.16.S3.1_bb0620","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1001\/jama.2010.1098","article-title":"Exposure to oral bisphosphonates and risk of esophageal cancer","volume":"304","author":"Cardwell","year":"2010","journal-title":"JAMA."},{"key":"10.4158\/EP.16.S3.1_bb0625","doi-asserted-by":"crossref","first-page":"c4444","DOI":"10.1136\/bmj.c4444","article-title":"Oral bisphosphonates and risk of cancer of oesophagus, stomach, and colorectum: case-control analysis within a UK primary care cohort","volume":"341","author":"Green","year":"2010","journal-title":"BMJ."},{"key":"10.4158\/EP.16.S3.1_bb0630","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa067312","article-title":"Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis","volume":"356","author":"Black","year":"2007","journal-title":"N Engl J Med."},{"key":"10.4158\/EP.16.S3.1_bb0635","series-title":"Fosamax [package insert]","year":"2010"},{"key":"10.4158\/EP.16.S3.1_bb0640","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","article-title":"Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures","volume":"348","author":"Black","year":"1996","journal-title":"Lancet"},{"key":"10.4158\/EP.16.S3.1_bb0645","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1001\/jama.280.24.2077","article-title":"Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial","volume":"280","author":"Cummings","year":"1998","journal-title":"JAMA."},{"key":"10.4158\/EP.16.S3.1_bb0650","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.1210\/jcem.85.11.6953","article-title":"Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial [published correction appears in J Clin Endocrinol Metab. 2001;86:938]","volume":"85","author":"Black","year":"2000","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.16.S3.1_bb0655","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/PL00004171","article-title":"Multinational, placebo-controlled, randomized trial of the effects of alendronate on bone density and fracture risk in postmenopausal women with low bone mass: results of the FOSIT study","volume":"9","author":"Pols","year":"1999","journal-title":"Osteoporos Int."},{"key":"10.4158\/EP.16.S3.1_bb0660","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1056\/NEJM199511303332201","article-title":"Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis","volume":"333","author":"Liberman","year":"1995","journal-title":"N Engl J Med."},{"key":"10.4158\/EP.16.S3.1_bb0665","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa030897","article-title":"(Alendronate Phase III Osteoporosis Treatment Study Group). Ten years\u2019 experience with alendronate for osteoporosis in postmenopausal women","volume":"350","author":"Bone","year":"2004","journal-title":"N Engl J Med."},{"key":"10.4158\/EP.16.S3.1_bb0670","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1001\/jama.296.24.2927","article-title":"Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX); a randomized trial","volume":"296","author":"Black","year":"2006","journal-title":"JAMA."},{"key":"10.4158\/EP.16.S3.1_bb0675","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1056\/NEJM199610033351412","article-title":"\u201cPill esophagitis\u201d\u2014the case of alendronate","volume":"335","author":"Castell","year":"1996","journal-title":"N Engl J Med."},{"key":"10.4158\/EP.16.S3.1_bb0680","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.1111\/j.1572-0241.2001.05291.x","article-title":"Fatal esophageal perforation with alendronate","volume":"96","author":"Famularo","year":"2001","journal-title":"Am J Gastroenterol."},{"key":"10.4158\/EP.16.S3.1_bb0685","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1001\/archinte.162.8.936","article-title":"Gastric and duodenal safety of daily alendronate","volume":"162","author":"Donahue","year":"2002","journal-title":"Arch Intern Med."},{"key":"10.4158\/EP.16.S3.1_bb0690","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.4065\/77.10.1044","article-title":"Tolerability of once-weekly alendronate in patients with osteoporosis: a randomized, double-blind, placebo-controlled study","volume":"77","author":"Greenspan","year":"2002","journal-title":"Mayo Clin Proc."},{"key":"10.4158\/EP.16.S3.1_bb0695","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1210\/jc.2009-1947","article-title":"Long-term use of bisphosphonates in osteoporosis","volume":"95","author":"Watts","year":"2010","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.16.S3.1_bb0700","series-title":"Actonel [package insert]","year":"2010"},{"key":"10.4158\/EP.16.S3.1_bb0705","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1001\/jama.282.14.1344","article-title":"Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial","volume":"282","author":"Harris","year":"1999","journal-title":"JAMA."},{"key":"10.4158\/EP.16.S3.1_bb0710","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s001980050010","article-title":"Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis","volume":"11","author":"Reginster","year":"2000","journal-title":"Osteoporos Int."},{"key":"10.4158\/EP.16.S3.1_bb0715","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1056\/NEJM200102013440503","article-title":"Effect of risedronate on the risk of hip fracture in elderly women","volume":"344","author":"McClung","year":"2001","journal-title":"N Engl J Med."},{"key":"10.4158\/EP.16.S3.1_bb0720","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S8756-3282(02)00946-8","article-title":"Longterm efficacy of risedronate: a 5-year placebo-controlled clinical experience","volume":"32","author":"Sorensen","year":"2003","journal-title":"Bone."},{"key":"10.4158\/EP.16.S3.1_bb0725","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s00223-004-0286-7","article-title":"Seven years of treatment with risedronate in women with postmenopausal osteoporosis","volume":"75","author":"Mellstr\u00f6m","year":"2004","journal-title":"Calcif Tissue Int."},{"key":"10.4158\/EP.16.S3.1_bb0730","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00198-007-0460-7","article-title":"Fracture risk remains reduced one year after discontinuation of risedronate","volume":"19","author":"Watts","year":"2008","journal-title":"Osteoporos Int."},{"key":"10.4158\/EP.16.S3.1_bb0735","series-title":"Boniva [package insert]","year":"2010"},{"key":"10.4158\/EP.16.S3.1_bb0740","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1359\/JBMR.040325","article-title":"Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis","volume":"19","author":"Chesnut","year":"2004","journal-title":"J Bone Miner Res."},{"key":"10.4158\/EP.16.S3.1_bb0745","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1359\/jbmr.0301202","article-title":"Oral daily ibandronate prevents bone loss in early postmenopausal women without osteoporosis","volume":"19","author":"McClung","year":"2004","journal-title":"J Bone Miner Res."},{"key":"10.4158\/EP.16.S3.1_bb0750","series-title":"Reclast [package insert]","year":"2010"},{"key":"10.4158\/EP.16.S3.1_bb0755","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.bone.2007.03.011","article-title":"Intravenous zoledronic acid 5 mg in the treatment of postmenopausal women with low bone density previously treated with alendronate","volume":"41","author":"McClung","year":"2007","journal-title":"Bone."},{"key":"10.4158\/EP.16.S3.1_bb0760","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0140-6736(09)60250-6","article-title":"Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial","volume":"373","author":"Reid","year":"2009","journal-title":"Lancet."},{"key":"10.4158\/EP.16.S3.1_bb0765","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1056\/NEJM199712043372301","article-title":"Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women","volume":"337","author":"Delmas","year":"1997","journal-title":"N Engl J Med."},{"key":"10.4158\/EP.16.S3.1_bb0770","series-title":"Evista [package insert]","year":"2008"},{"key":"10.4158\/EP.16.S3.1_bb0775","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.282.7.637","article-title":"Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial","volume":"282","author":"Ettinger","year":"1999","journal-title":"JAMA."},{"key":"10.4158\/EP.16.S3.1_bb0780","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1210\/jcem.87.8.8750","article-title":"(Multiple Outcomes of Raloxifene Evaluation Investigators). Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: four-year results from a randomized clinical trial","volume":"87","author":"Delmas","year":"2002","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.16.S3.1_bb0785","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa062462","article-title":"(Raloxifene Use for the Heart [RUTH] Trial Investigators). Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women","volume":"355","author":"Barrett-Connor","year":"2006","journal-title":"N Engl J Med."},{"key":"10.4158\/EP.16.S3.1_bb0790","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1001\/jama.295.23.joc60074","article-title":"(National Surgical Adjuvant Breast and Bowel Project [NSABP]). Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial","volume":"295","author":"Vogel","year":"2006","journal-title":"JAMA."},{"key":"10.4158\/EP.16.S3.1_bb0795","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1359\/JBMR.050509","article-title":"(Continuing Outcomes Relevant to Evista [CORE] Investigators). Skeletal effects of raloxifene after 8 years: results from the Continuing Outcomes Relevant to Evista (CORE) study","volume":"20","author":"Siris","year":"2005","journal-title":"J Bone Miner Res."},{"key":"10.4158\/EP.16.S3.1_bb0800","series-title":"Forteo [package insert].","year":"2010"},{"key":"10.4158\/EP.16.S3.1_bb0805","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"N Engl J Med."},{"key":"10.4158\/EP.16.S3.1_bb0810","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1359\/jbmr.081256","article-title":"Vertebral fracture risk is reduced in women who lose femoral neck BMD with teriparatide treatment","volume":"24","author":"Watts","year":"2009","journal-title":"J Bone Miner Res."},{"key":"10.4158\/EP.16.S3.1_bb0815","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1080\/01926230252929882","article-title":"Skeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone (1-34) for 2 years and relevance to human safety","volume":"30","author":"Vahle","year":"2002","journal-title":"Toxicol Pathol."},{"key":"10.4158\/EP.16.S3.1_bb0820","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1080\/01926230490462138","article-title":"Bone neoplasms in F344 rats given teriparatide [rhPTH(1-34)] are dependent on duration of treatment and dose","volume":"32","author":"Vahle","year":"2004","journal-title":"Toxicol Pathol."},{"key":"10.4158\/EP.16.S3.1_bb0825","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1359\/jbmr.061111","article-title":"Osteosarcoma and teriparatide?","volume":"22","author":"Harper","year":"2007","journal-title":"J Bone Miner Res."},{"key":"10.4158\/EP.16.S3.1_bb0830","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s00198-009-1004-0","article-title":"Of mice and men: divergent risks of teriparatide-induced osteosarcoma","volume":"21","author":"Subbiah","year":"2010","journal-title":"Osteoporos Int."},{"key":"10.4158\/EP.16.S3.1_bb0835","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1001\/archinte.164.18.2024","article-title":"Sustained vertebral fracture risk reduction after withdrawal of teriparatide in postmenopausal women with osteoporosis","volume":"164","author":"Lindsay","year":"2004","journal-title":"Arch Intern Med."},{"key":"10.4158\/EP.16.S3.1_bb0840","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1056\/NEJMoa050336","article-title":"One year of alendronate after one year of parathyroid hormone (1-84) for osteoporosis","volume":"353","author":"Black","year":"2005","journal-title":"N Engl J Med."},{"key":"10.4158\/EP.16.S3.1_bb0845","series-title":"Fortical [package insert]","year":"2009"},{"key":"10.4158\/EP.16.S3.1_bb0850","series-title":"Miacalcin [package insert]","year":"2009"},{"key":"10.4158\/EP.16.S3.1_bb0855","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0002-9343(00)00490-3","article-title":"A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the Prevent Recurrence Of Osteoporotic Fractures study","volume":"109","author":"Chesnut","year":"2000","journal-title":"Am J Med."},{"key":"10.4158\/EP.16.S3.1_bb0860","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis [published correction appears in N Engl J Med. 2009;361:1914]","volume":"361","author":"Cummings","year":"2009","journal-title":"N Engl J Med."},{"key":"10.4158\/EP.16.S3.1_bb0865","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1210\/jc.2007-2814","article-title":"Effects of denosumab on bone mineral density and bone turnover in postmenopausal women","volume":"93","author":"Bone","year":"2008","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.16.S3.1_bb0870","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.bone.2008.04.007","article-title":"Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: a randomized blinded phase 2 clinical trial","volume":"43","author":"Miller","year":"2008","journal-title":"Bone"},{"key":"10.4158\/EP.16.S3.1_bb0875","series-title":"Premarin [package insert]","year":"2010"},{"key":"10.4158\/EP.16.S3.1_bb0880","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/jama.290.13.1729","article-title":"Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women\u2019s Health Initiative randomized trial","volume":"290","author":"Cauley","year":"2003","journal-title":"JAMA."},{"key":"10.4158\/EP.16.S3.1_bb0885","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1359\/jbmr.060312","article-title":"(Women\u2019s Health Initiative Investigators). Effects of conjugated equine estrogen on risk of fractures and BMD in postmenopausal women with hysterectomy: results from the Women\u2019s Health Initiative randomized trial","volume":"21","author":"Jackson","year":"2006","journal-title":"J Bone Miner Res."},{"key":"10.4158\/EP.16.S3.1_bb0890","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1001\/jama.1996.03540170033029","article-title":"Effects of hormone therapy on bone mineral density: results from the Postmenopausal Estrogen\/Progestin Interventions (PEPI) trial","volume":"276","author":"Writing Group for the PEPI","year":"1996","journal-title":"JAMA."},{"key":"10.4158\/EP.16.S3.1_bb0895","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1001\/archinte.1997.00440430091011","article-title":"(Estratab\/Osteoporosis Study Group). Low-dose esterified estrogen therapy: effects on bone, plasma estradiol concentrations, endometrium, and lipid levels","volume":"157","author":"Genant","year":"1997","journal-title":"Arch Intern Med."},{"key":"10.4158\/EP.16.S3.1_bb0900","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1001\/jama.287.20.2668","article-title":"Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women","volume":"287","author":"Lindsay","year":"2002","journal-title":"JAMA."},{"key":"10.4158\/EP.16.S3.1_bb0905","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women\u2019s Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA."},{"key":"10.4158\/EP.16.S3.1_bb0910","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","article-title":"Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women\u2019s Health Initiative randomized controlled trial","volume":"291","author":"Anderson","year":"2004","journal-title":"JAMA."},{"key":"10.4158\/EP.16.S3.1_bb0915","doi-asserted-by":"crossref","first-page":"4914","DOI":"10.1210\/jc.2002-020727","article-title":"Effect of discontinuation of estrogen, calcitriol, and the combination of both on bone density and bone markers","volume":"87","author":"Gallagher","year":"2002","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.16.S3.1_bb0920","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1046\/j.1365-2265.2002.01536.x","article-title":"Combination therapy for postmenopausal osteoporosis","volume":"56","author":"Compston","year":"2002","journal-title":"Clin Endocrinol (Oxf)."},{"key":"10.4158\/EP.16.S3.1_bb0925","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMoa031975","article-title":"(PaTH Study Investigators). The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis","volume":"349","author":"Black","year":"2003","journal-title":"N Engl J Med."},{"key":"10.4158\/EP.16.S3.1_bb0930","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1056\/NEJM199007123230201","article-title":"Intermittent cyclical etidronate treatment of postmenopausal osteoporosis","volume":"323","author":"Watts","year":"1990","journal-title":"N Engl J Med."},{"key":"10.4158\/EP.16.S3.1_bb0935","series-title":"Aredia [package insert]","year":"2008"},{"key":"10.4158\/EP.16.S3.1_bb0940","series-title":"Didronel [package insert]","year":"2010"},{"key":"10.4158\/EP.16.S3.1_bb0945","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0378-5122(96)01118-8","article-title":"Cyclical pamidronate infusions in postmenopausal osteoporosis","volume":"25","author":"Peretz","year":"1996","journal-title":"Maturitas."},{"key":"10.4158\/EP.16.S3.1_bb0950","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1002\/jbmr.5650091216","article-title":"Femoral bone loss progresses with age: a longitudinal study in women over age 65","volume":"9","author":"Greenspan","year":"1994","journal-title":"J Bone Miner Res."},{"key":"10.4158\/EP.16.S3.1_bb0955","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1002\/jbmr.5650100806","article-title":"Vitamin D status and sex hormone binding globulin: determinants of bone turnover and bone mineral density in elderly women","volume":"10","author":"Ooms","year":"1995","journal-title":"J Bone Miner Res."},{"key":"10.4158\/EP.16.S3.1_bb0960","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0889-857X(05)70196-4","article-title":"An update on glucocorticoid-induced osteoporosis","volume":"27","author":"Lane","year":"2001","journal-title":"Rheum Dis Clin North Am."},{"key":"10.4158\/EP.16.S3.1_bb0965","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1007\/s00198-008-0661-8","article-title":"Assessing response to osteoporosis therapy","volume":"19","author":"Lewiecki","year":"2008","journal-title":"Osteoporos Int."},{"issue":"suppl","key":"10.4158\/EP.16.S3.1_bb0970","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1385\/JCD:5:3S:S29","article-title":"What is the role of serial bone mineral density measurements in patient management?","volume":"5","author":"Lenchik","year":"2002","journal-title":"J Clin Densitom."},{"key":"10.4158\/EP.16.S3.1_bb0975","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1385\/JCD:8:4:371","article-title":"Precision assessment and radiation safety for dual-energy x-ray absorptiometry: position paper of the International Society for Clinical Densitometry","volume":"8","author":"Baim","year":"2005","journal-title":"J Clin Densitom."},{"issue":"suppl 2","key":"10.4158\/EP.16.S3.1_bb0980","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/S1098-3597(03)90043-3","article-title":"Mechanisms of osteoporosis therapy: a bone strength perspective","volume":"5","author":"Bouxsein","year":"2003","journal-title":"Clin Cornerstone."},{"key":"10.4158\/EP.16.S3.1_bb0985","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1210\/jcem.87.4.8415","article-title":"Changes in bone density and turnover explain the reductions in incidence of nonvertebral fractures that occur during treatment with antiresorp-tive agents","volume":"87","author":"Hochberg","year":"2002","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.16.S3.1_bb0990","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0002-9343(03)00362-0","article-title":"Early discontinuation of treatment for osteoporosis","volume":"115","author":"Tosteson","year":"2003","journal-title":"Am J Med."},{"key":"10.4158\/EP.16.S3.1_bb0995","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1385\/JCD:4:4:373","article-title":"Instant vertebral assessment: a noninvasive dual x-ray absorptiometry technique to avoid misclassification and clinical mismanagement of osteoporosis","volume":"4","author":"Greenspan","year":"2001","journal-title":"J Clin Densitom."},{"key":"10.4158\/EP.16.S3.1_bb1000","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00198-005-2010-5","article-title":"Reliability and accuracy of vertebral fracture assessment with densitometry compared to radiography in clinical practice","volume":"17","author":"Schousboe","year":"2006","journal-title":"Osteoporos Int."},{"key":"10.4158\/EP.16.S3.1_bb1005","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1007\/s00198-005-1891-7","article-title":"Lateral vertebral assessment: a valuable technique to detect clinically significant vertebral fractures","volume":"16","author":"Binkley","year":"2005","journal-title":"Osteoporos Int."},{"key":"10.4158\/EP.16.S3.1_bb1010","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jocd.2007.12.008","article-title":"Vertebral Fracture Assessment: the 2007 ISCD Official Positions","volume":"11","author":"Schousboe","year":"2008","journal-title":"J Clin Densitom."},{"key":"10.4158\/EP.16.S3.1_bb1015","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1210\/jc.2004-1091","volume":"90","author":"Greenspan","year":"2005","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.16.S3.1_bb1020","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1210\/jc.2005-1712","article-title":"Short-term changes in bone turnover markers and bone mineral density response to parathyroid hormone in postmenopausal women with osteoporosis","volume":"91","author":"Bauer","year":"2006","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.16.S3.1_bb1025","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.rcl.2010.02.020","article-title":"Percutaneous vertebroplasty or kyphoplasty","volume":"48","author":"Anselmetti","year":"2010","journal-title":"Radiol Clin North Am."},{"key":"10.4158\/EP.16.S3.1_bb1030","first-page":"429","article-title":"The present role of vertebroplasty and kyphoplasty in the treatment of fresh vertebral compression fractures","volume":"65","author":"R\u00f6llinghoff","year":"2010","journal-title":"Minerva Chir."},{"key":"10.4158\/EP.16.S3.1_bb1035","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1056\/NEJMoa0900429","article-title":"A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures","volume":"361","author":"Buchbinder","year":"2009","journal-title":"N Engl J Med."},{"key":"10.4158\/EP.16.S3.1_bb1040","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1056\/NEJMoa0900563","article-title":"A randomized trial of vertebroplasty for osteoporotic spinal fractures","volume":"361","author":"Kallmes","year":"2009","journal-title":"N Engl J Med."},{"key":"10.4158\/EP.16.S3.1_bb1045","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1007\/s00198-006-0195-x","article-title":"Vertebral height restoration in osteoporotic compression fractures: kyphoplasty balloon tamp is superior to postural correction alone","volume":"17","author":"Shindle","year":"2006","journal-title":"Osteoporos Int."}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20464407?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20464407?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/813555L642H443V5.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:50:29Z","timestamp":1761515429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20464407"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":209,"alternative-id":["S1530891X20464407"],"URL":"https:\/\/doi.org\/10.4158\/ep.16.s3.1","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Postmenopausal Osteoporosis","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP.16.S3.1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}